Resistin Concentration in Early Sepsis and All-Cause Mortality at a Safety-Net Hospital in Riverside County

References

• Beutler B, Poltorak A. Sepsis and evolution of the innate immune response. Crit Care Med. 2001;29(7Suppl):S2–6;discussion S6–7. doi:10.1097/00003246-200107001-00002
   Web of Science ®Google Scholar
• Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377. doi:10.1056/NEJMoa010307
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377. doi:10.1007/s00134-017-4683-6
   PubMed Web of Science ®Google Scholar
• Yealy DM, Kellum JA, Huang DT, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–1693. doi:10.1056/NEJMoa1401602
   PubMed Web of Science ®Google Scholar
• Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–1506. doi:10.1056/NEJMoa1404380
   PubMed Web of Science ®Google Scholar
• Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–1311. doi:10.1056/NEJMoa1500896
   PubMed Web of Science ®Google Scholar
• Soong J, Soni N. Sepsis: recognition and treatment. Clin Med. 2012;12(3):276–280. doi:10.7861/clinmedicine.12-3-276
   PubMed Web of Science ®Google Scholar
• Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med. 2014;42(3):625–631. doi:10.1097/CCM.0000000000000026
   PubMed Web of Science ®Google Scholar
• Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272. doi:10.1164/rccm.201504-0781OC
   PubMed Web of Science ®Google Scholar
• Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2010;376(9749):1339–1346. doi:10.1016/S0140-6736(10)60446-1
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307–312. doi:10.1038/35053000
   PubMed Web of Science ®Google Scholar
• Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174(9):5789–5795. doi:10.4049/jimmunol.174.9.5789
   PubMed Web of Science ®Google Scholar
• Konrad A, Lehrke M, Schachinger V, et al. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol. 2007;19(12):1070–1074. doi:10.1097/MEG.0b013e3282f16251
   PubMed Web of Science ®Google Scholar
• Almehed K, d’Elia HF, Bokarewa M, Carlsten H. Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther. 2008;10(1):R15. doi:10.1186/ar2366
   PubMed Web of Science ®Google Scholar
• Ellington AA, Malik AR, Klee GG, et al. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension. 2007;50(4):708–714. doi:10.1161/HYPERTENSIONAHA.107.095257
   PubMed Web of Science ®Google Scholar
• Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111(7):932–939. doi:10.1161/01.CIR.0000155620.10387.43
   PubMed Web of Science ®Google Scholar
• Ohmori R, Momiyama Y, Kato R, et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol. 2005;46(2):379–380. doi:10.1016/j.jacc.2005.04.022
   PubMed Web of Science ®Google Scholar
• Qiao XZ, Yang YM, Xu ZR, Yang LA. Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris. J Zhejiang Univ Sci B. 2007;8(12):875–880. doi:10.1631/jzus.2007.B0875
   PubMedGoogle Scholar
• Zuniga MC, Raghuraman G, Hitchner E, Weyand C, Robinson W, Zhou W. PKC-epsilon and TLR4 synergistically regulate resistin-mediated inflammation in human macrophages. Atherosclerosis. 2017;259:51–59. doi:10.1016/j.atherosclerosis.2017.02.021
   PubMed Web of Science ®Google Scholar
• Lv M, Liu W. Hypoxia-induced mitogenic factor: a multifunctional protein involved in health and disease. Front Cell Dev Biol. 2021;9:691774. doi:10.3389/fcell.2021.691774
   PubMed Web of Science ®Google Scholar
• Ehrnthaller C, Flierl M, Perl M, et al. The molecular fingerprint of lung inflammation after blunt chest trauma. Eur J Med Res. 2015;20:70. doi:10.1186/s40001-015-0164-y
   PubMed Web of Science ®Google Scholar
• Macdonald SP, Stone SF, Neil CL, et al. Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department. PLoS One. 2014;9(10):e110678. doi:10.1371/journal.pone.0110678
   PubMed Web of Science ®Google Scholar
• Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care. 2009;13(3):R95. doi:10.1186/cc7925
   PubMed Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med. 1996;22(7):707–710. doi:10.1007/BF01709751
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829. doi:10.1097/00003246-198510000-00009
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Grissom CK, Brown SM, Kuttler KG, et al. A modified sequential organ failure assessment score for critical care triage. Disaster Med Public Health Prep. 2010;4(4):277–284. doi:10.1001/dmp.2010.40
   PubMed Web of Science ®Google Scholar
• Wei T, Viliam S, Package R. “corrplot”: visualization of a correlation matrix; 2017.
   Google Scholar
• Malyszko J, Malyszko JS, Kozminski P, Pawlak K, Mysliwiec M. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients. Nephrology. 2007;12(3):246–253. doi:10.1111/j.1440-1797.2007.00782.x
   PubMed Web of Science ®Google Scholar
• Cohen G, Ilic D, Raupachova J, Hörl WH. Resistin inhibits essential functions of polymorphonuclear leukocytes. J Immunol. 2008;181(6):3761–3768. doi:10.4049/jimmunol.181.6.3761
   PubMed Web of Science ®Google Scholar
• Parnell GP, Tang BM, Nalos M, et al. Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions. Shock. 2013;40(3):166–174. doi:10.1097/SHK.0b013e31829ee604
   PubMed Web of Science ®Google Scholar
• Cekmez F, Canpolat FE, Cetinkaya M, et al. Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis. Eur Cytokine Netw. 2011;22(2):113–117. doi:10.1684/ecn.2011.0283
   PubMed Web of Science ®Google Scholar
• Karampela I, Christodoulatos GS, Kandri E, et al. Circulating eNampt and resistin as a proinflammatory duet predicting independently mortality in critically ill patients with sepsis: a prospective observational study. Cytokine. 2019;119:62–70. doi:10.1016/j.cyto.2019.03.002
   PubMed Web of Science ®Google Scholar
• Aliefendioglu D, Gürsoy T, Çağlayan O, Aktaş A, Ovalı F. Can resistin be a new indicator of neonatal sepsis? Pediatr Neonatol. 2014;55(1):53–57. doi:10.1016/j.pedneo.2013.04.012
   PubMed Web of Science ®Google Scholar
• Gokmen Z, Ozkiraz S, Kulaksizoglu S, et al. Resistin–a novel feature in the diagnosis of sepsis in premature neonates. Am J Perinatol. 2013;30(6):513–517. doi:10.1055/s-0032-1329182
   PubMed Web of Science ®Google Scholar
• Qiu X, Li J, Bonenfant J, et al. Dynamic changes in human single-cell transcriptional signatures during fatal sepsis. J Leukoc Biol. 2021;110(6):1253–1268. doi:10.1002/JLB.5MA0721-825R
   PubMed Web of Science ®Google Scholar
• Sundén-Cullberg J, Nyström T, Lee ML, et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med. 2007;35(6):1536–1542. doi:10.1097/01.CCM.0000266536.14736.03
   PubMed Web of Science ®Google Scholar
• Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 2002;530(1–3):158–162. doi:10.1016/s0014-5793(02)03450-6
   PubMed Web of Science ®Google Scholar
• Rajala MW, Lin Y, Ranalletta M, et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol. 2002;16(8):1920–1930. doi:10.1210/me.2002-0048
   PubMedGoogle Scholar
• Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010;14(6B):1419–1431. doi:10.1111/j.1582-4934.2009.00899.x
   PubMed Web of Science ®Google Scholar
• Jang JC, Li J, Gambini L, et al. Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction. Proc Natl Acad Sci U S A. 2017;114(48):E10399–E10408. doi:10.1073/pnas.1716015114
   PubMed Web of Science ®Google Scholar
• Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66(Suppl 2):ii33–40. doi:10.1093/jac/dkq523
   PubMed Web of Science ®Google Scholar